Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06185010
Other study ID # University of Beira Interior
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date December 1, 2023
Est. completion date April 2024

Study information

Verified date December 2023
Source University of Beira Interior
Contact Nuno Fonseca, Master's
Phone 918241354
Email nuno1977fonseca@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This research project aims to analyze the effects of different resistance training volumes on cognitive function, oxidative stress, immunological response, lipid profile, glycemic status, liver function, muscle function, hemodynamic response, and physical performance in individuals with mild cognitive impairment. First the investigators will analyze the effects of a single resistance training session (acute effects) with one and three sets on hemodynamic and physical performance in individuals with mild cognitive impairment. After, the investigators will analyze the effects of an 8-week resistance training program with one or three sets on cognitive function, oxidative stress, immunological response, lipid profile, glycemic status, liver function, muscle function, hemodynamic response, and physical performance in individuals with mild cognitive impairment. The investigators hypothesize that a single resistance training session of one or three sets will increase the acute hemodynamic and physical performance stress in individuals with mild cognitive impairment, although with a higher magnitude in the session with three sets. Furthermore, we hypothesize that eight weeks of resistance training with one or three sets will induce similar improvements in cognitive function, oxidative stress, immunological response, lipid profile, glycemic status, liver function, muscle function, hemodynamic response, and physical performance in individuals with mild cognitive impairment.


Description:

Following specific inclusion and exclusion criteria (see Eligibility Criteria), participants will be recruited from residential care facilities or day centers. For the acute effects study (cross-over study), participants will randomly perform two resistance training sessions separated by one week of rest: i) one session with one set and ii) another session of three sets. The intensity of the exercises, number of repetitions, type and order of exercises, movement velocity, and rest time between exercises will be the same in both groups. Before, immediately after, and 72 hours after the sessions, a battery of tests will be applied to evaluate the changes in blood pressure, heart rate, tympanic temperature, medicine ball throw distance, five-repetition sit-to-stand time, and handgrip strength. Afterward, participants will be randomly assigned into a one-set or three-set group to perform an eight-week resistance training intervention. As for the acute effects study, the prescription of the other acute training variables will be the same for both groups. A control group (without any form of physical exercise), recruited at the beginning of the research project, will also be part of the study. Before and after the intervention, a battery of tests will be applied to determine the training program's impact on cognitive function, oxidative stress, immunological response, lipid profile, glycemic status, liver function, muscle function, hemodynamic response, and physical performance in individuals with mild cognitive impairment.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date April 2024
Est. primary completion date April 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 50 Years and older
Eligibility Inclusion criteria: - Clinical diagnosis of mild cognitive impairment - SPPB score = 3 points - Willingness to participate in the interventions and collaborate with the research team - Must be able to provide informed consent (oral or written) Exclusion criteria: - Severe dementia - Severe comorbidity that negatively influences participation in the intervention - Color blindness - Fractures in the last three months

Study Design


Intervention

Other:
One Resistance Training Set (Single Session)
The participants will perform a resistance training session with one set per exercise. The training sequence will be the following: i) 10 minutes of warm-up walking on the treadmill at 50% of maximal walking velocity, ii) 1 set of 10 repetitions at 60% of one-repetition maximum (1RM) in the leg press, iii) 1 set of 10 repetitions at 55% 1RM in the chest press, iv) 1 set of 10 repetitions in the sit-to-stand exercise, v) 1 set of 10 repetitions in the 1-kg medicine ball throw exercise, and vi) 5 minutes walking on the treadmill at 60% of maximal walking velocity.
Three Resistance Training Sets (Single Session)
The participants will perform a resistance training session with three sets per exercise. The training sequence will be the following: i) 10 minutes of warm-up walking on the treadmill at 50% of maximal walking velocity, ii) 3 sets of 10 repetitions at 60% of one-repetition maximum (1RM) in the leg press, iii) 3 sets of 10 repetitions at 55% 1RM in the chest press, iv) 3 sets of 10 repetitions in the sit-to-stand exercise, v) 3 sets of 10 repetitions in the 1-kg medicine ball throw exercise, and vi) 5 minutes walking on the treadmill at 60% of maximal walking velocity.
One Resistance Training Set (8 Weeks)
The participants will perform eight weeks of resistance training with one set per exercise. The training sequence will be the following: i) 10 minutes of warm-up walking on the treadmill at 50% of maximal walking velocity, ii) 1 set of 10 repetitions between 50-70% of one-repetition maximum (1RM) in the leg press, iii) 1 set of 10 repetitions between 40-60% 1RM in the chest press, iv) 1 set of 6-12 repetitions in the sit-to-stand exercise, v) 1 set of 6-12 repetitions in the 1-kg medicine ball throw exercise, and vi) 5 minutes walking on the treadmill at 60% of maximal walking velocity.
Three Resistance Training Sets (8 Weeks)
The participants will perform eight weeks of resistance training with three sets per exercise. The training sequence will be the following: i) 10 minutes of warm-up walking on the treadmill at 50% of maximal walking velocity, ii) 3 sets of 10 repetitions between 50-70% of one-repetition maximum (1RM) in the leg press, iii) 3 sets of 10 repetitions between 40-60% 1RM in the chest press, iv) 3 sets of 6-12 repetitions in the sit-to-stand exercise, v) 3 sets of 6-12 repetitions in the 1-kg medicine ball throw exercise, and vi) 5 minutes walking on the treadmill at 60% of maximal walking velocity.
Control (8 Weeks)
The participants in the control group will maintain their regular daily activities without performing any form of physical exercise.

Locations

Country Name City State
Portugal University of Beira Interior Covilhã

Sponsors (2)

Lead Sponsor Collaborator
University of Beira Interior Research Center in Sports Sciences, Health Sciences and Human Development (CIDESD)

Country where clinical trial is conducted

Portugal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Systolic blood pressure (SBP) In the cross-over study (acute effects), the SBP will be assessed through a blood pressure device. Change from baseline to 0 minutes and 72 hours after the sessions
Primary Handgrip strength (HGS) In the cross-over study (acute effects), the HGS will be assessed through an analogic dynamometer. Change from baseline to 0 minutes and 72 hours after the sessions
Primary Dementia Rating Scale-2 (DRS-2) In the eight-week study, the DRS-2 questionnaire will be applied to analyze the overall level of cognitive function through five subscales: attention, initiation/perseveration, construction, conceptualization, and memory. Change from baseline to week 8
Primary Brain-Derived Neurotrophic Factor (BDNF) In the eight-week study, the BDNF protein levels will be analyzed through specific blood testing kits. Change from baseline to week 8
Primary Short Physical Performance Battery (SPPB) In the eight-week study, the SPPB will determine the overall level of functional performance through three tests: balance (feet side by side, semi tandem, tandem), 4-meter walking, and 5-repetition sit-to-stand. Change from baseline until week 8
Secondary Diastolic blood pressure (DBP) In the cross-over study (acute effects), the DBP will be assessed through a blood pressure device. Change from baseline to 0 minutes and 72 hours after the sessions
Secondary Heart rate (HR) In the cross-over study (acute effects), the HR will be assessed through a blood pressure device. Change from baseline to 0 minutes and 72 hours after the sessions
Secondary Tympanic temperature (TT) In the cross-over study (acute effects), the TT will be assessed through a tympanic thermometer. Change from baseline to 0 minutes and 72 hours after the sessions
Secondary Five-repetition sit-to-stand (5STS) In the cross-over study (acute effects), the 5STS time will be recorded through a chronometer. Change from baseline to 0 minutes and 72 hours after the sessions
Secondary 1-kg Medicine Ball Throw (MBT) In the cross-over study (acute effects), the MBT distance will be recorded with a tape measure. Change from baseline to 0 minutes and 72 hours after the sessions
Secondary Inflammatory markers In the eight-week study, inflammatory markers (IL-6, TNF-a, and IL-10) will be analyzed through specific blood testing kits. Change from baseline to week 8
Secondary Oxidative stress In the eight-week study, oxidative stress markers (carbonylated proteins) will be analyzed through specific blood testing kits. Change from baseline to week 8
Secondary Lipid Profile In the eight-week study, the lipid profile (LDL, HDL, total cholesterol, triglycerides) will be analyzed through specific blood testing kits. Change from baseline to week 8
Secondary HbA1c In the eight-week study, the HbA1c will be analyzed through specific blood testing kits. Change from baseline to week 8
Secondary Muscle Damage In the eight-week study, the muscle damage (creatine kinase, lactate dehydrogenase, aspartate aminotransferase, and alanine aminotransferase) will be analyzed through specific blood testing kits. Change from baseline to week 8
Secondary One-repetition maximum (1RM) In the eight-week study, a progressive loading test until reaching the 1RM will be applied in the horizontal leg press and seated chest press machines. Change from baseline to week 8
Secondary Load-velocity profiles In the eight-week study, the load-velocity profiles will be analyzed using the velocity values (recorded with a linear velocity transducer) associated with the absolute loads used during the progressive loading tests in the horizontal leg press and seated chest press machines. Change from baseline to week 8
Secondary Ten-meters walking In the eight-week study, the 10-meter walking time will be measured through a chronometer. Change from baseline to week 8
Secondary 1-kg Medicine Ball Throw (MBT) In the eight-week study, the MBT distance will be recorded with a tape measure. Change from baseline to week 8
Secondary Handgrip strength (HGS) In the eight-week study, the HGS will be assessed through an analogic dynamometer. Change from baseline to week 8
Secondary 6-Minute Walk Test (6MWT) In the eight-week study, the 6MWT distance will be assessed by multiplying the number of total laps by the lap distance (e.g., 10 laps x 10 meters). Change from baseline to week 8
See also
  Status Clinical Trial Phase
Completed NCT04513106 - Promoting Advance Care Planning for Persons With Early-stage Dementia in the Community: a Feasibility Trial N/A
Recruiting NCT06011681 - The Rapid Diagnosis of MCI and Depression in Patients Ages 60 and Over
Recruiting NCT04522739 - Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease Phase 4
Active, not recruiting NCT03167840 - Falls Prevention Through Physical And Cognitive Training in Mild Cognitive Impairment N/A
Active, not recruiting NCT03676881 - Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
Not yet recruiting NCT05041790 - A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment Phase 4
Recruiting NCT04121156 - High Definition Transcranial Direct Current Stimulation (HD-tDCS) in Patients With Mild Cognitive Impairment N/A
Recruiting NCT03605381 - MORbidity PRevalence Estimate In StrokE
Completed NCT02774083 - Cognitive Training Using Feuerstein Instrumental Enrichment N/A
Completed NCT01315639 - New Biomarker for Alzheimer's Disease Diagnostic N/A
Enrolling by invitation NCT06023446 - Can (Optical Coherence Tomography) Pictures of the Retina Detect Alzheimer's Disease at Its Earliest Stages?
Completed NCT04567745 - Automated Retinal Image Analysis System (EyeQuant) for Computation of Vascular Biomarkers Phase 1
Recruiting NCT05579236 - Cortical Disarray Measurement in Mild Cognitive Impairment and Alzheimer's Disease
Completed NCT03583879 - Using Gait Robotics to Improve Symptoms of Parkinson's Disease N/A
Terminated NCT02503501 - Intranasal Glulisine in Amnestic Mild Cognitive Impairment and Probable Mild Alzheimer's Disease Phase 2
Not yet recruiting NCT03740178 - Multiple Dose Trial of MK-4334 in Participants With Alzheimer's Clinical Syndrome (MK-4334-005) Phase 1
Active, not recruiting NCT05204940 - Longitudinal Observational Biomarker Study
Recruiting NCT02663531 - Retinal Neuro-vascular Coupling in Patients With Neurodegenerative Disease N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Recruiting NCT03507192 - Effects of Muscle Relaxation on Cognitive Function in Patients With Mild Cognitive Impairment and Early Stage Dementia. N/A